Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin vs metformin in women with polycystic ovary syndrome
IRCT20210210050315N1Phase 3Completed
- Sponsor
- Arak University
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of empagliflozin and metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Arak University. Started Nov 2024; status: completed.
02
Drugs
empagliflozinmetformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20210210050315N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210210050315N1.